vs

Side-by-side financial comparison of CME Group (CME) and CIMPRESS plc (CMPR). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.0B, roughly 1.8× CIMPRESS plc). CIMPRESS plc runs the higher net margin — 4.7% vs 0.1%, a 4.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 11.0%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Cimpress plc is an American Irish-domiciled multinational technology company that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods. Those products are sold to small businesses, graphic designers and consumers through a number of customer-facing brands that Cimpress operates.

CME vs CMPR — Head-to-Head

Bigger by revenue
CME
CME
1.8× larger
CME
$1.9B
$1.0B
CMPR
Growing faster (revenue YoY)
CME
CME
+3.5% gap
CME
14.5%
11.0%
CMPR
Higher net margin
CMPR
CMPR
4.7% more per $
CMPR
4.7%
0.1%
CME

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CME
CME
CMPR
CMPR
Revenue
$1.9B
$1.0B
Net Profit
$1.2M
$49.3M
Gross Margin
46.8%
Operating Margin
0.1%
8.5%
Net Margin
0.1%
4.7%
Revenue YoY
14.5%
11.0%
Net Profit YoY
20.7%
-19.2%
EPS (diluted)
$1.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
CMPR
CMPR
Q1 26
$1.9B
Q4 25
$1.6B
$1.0B
Q3 25
$1.5B
$863.3M
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
Net Profit
CME
CME
CMPR
CMPR
Q1 26
$1.2M
Q4 25
$1.2B
$49.3M
Q3 25
$908.0M
$7.6M
Q2 25
$1.0B
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
Gross Margin
CME
CME
CMPR
CMPR
Q1 26
Q4 25
46.8%
Q3 25
46.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
CME
CME
CMPR
CMPR
Q1 26
0.1%
Q4 25
61.8%
8.5%
Q3 25
63.3%
5.7%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
CME
CME
CMPR
CMPR
Q1 26
0.1%
Q4 25
71.7%
4.7%
Q3 25
59.1%
0.9%
Q2 25
60.6%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
EPS (diluted)
CME
CME
CMPR
CMPR
Q1 26
Q4 25
$3.24
$1.95
Q3 25
$2.49
$0.30
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
CMPR
CMPR
Cash + ST InvestmentsLiquidity on hand
$2.4B
$258.0M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$-530.7M
Total Assets
$202.0B
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
CMPR
CMPR
Q1 26
$2.4B
Q4 25
$4.5B
$258.0M
Q3 25
$2.6B
$200.5M
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
CMPR
CMPR
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
CMPR
CMPR
Q1 26
Q4 25
$28.7B
$-530.7M
Q3 25
$28.2B
$-571.3M
Q2 25
$27.7B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
Total Assets
CME
CME
CMPR
CMPR
Q1 26
$202.0B
Q4 25
$198.4B
$2.1B
Q3 25
$187.1B
$2.0B
Q2 25
$179.9B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
CMPR
CMPR
Operating Cash FlowLast quarter
$164.7M
Free Cash FlowOCF − Capex
$139.5M
FCF MarginFCF / Revenue
13.4%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.34×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
CMPR
CMPR
Q1 26
Q4 25
$1.1B
$164.7M
Q3 25
$968.1M
$25.1M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$776.9M
Free Cash Flow
CME
CME
CMPR
CMPR
Q1 26
Q4 25
$1.1B
$139.5M
Q3 25
$949.7M
$-1.3M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
CME
CME
CMPR
CMPR
Q1 26
Q4 25
66.8%
13.4%
Q3 25
61.8%
-0.1%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
CME
CME
CMPR
CMPR
Q1 26
Q4 25
2.0%
2.4%
Q3 25
1.2%
3.1%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
CME
CME
CMPR
CMPR
Q1 26
Q4 25
0.96×
3.34×
Q3 25
1.07×
3.28×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

CMPR
CMPR

Vista$532.8M51%
Print Brothers$219.9M21%
National Pen$150.9M14%
The Print Group$115.2M11%
All Other Businesses$67.2M6%

Related Comparisons